Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI-589 in Parkinson's Disease
NCT02462603Phase 2Completed
- Sponsor
- Bioelectron
- Start
- May 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of EPI-589 in Parkinson's disease (PD), sponsored by Bioelectron. Started May 2016; status: completed.
02
Drugs
EPI-589
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02462603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462603.